Lung cancer is considered the most frequently lethal tumor disease. DZL scientists have shown that the reprogramming of a specific group of white blood cells, known as tumor-associated macrophages, could be a promising approach for...
In collaboration with this year's Nobel Prize winner for physics, Ferenc Krausz, the Ludwig Maximilian University Hospital was the first to test the clinical application of the groundbreaking laser technology. The joint project “Laser4Life” started...
DZL scientist Prof. Dr. Soni Savai Pullamsetti and her team have discovered signalling pathways involved in developing right heart failure in patients with pulmonary hypertension. The findings provide new biomarkers for diagnosis and targets for...
A group led by Marburg-based DZL researcher Professor Dr Bernd Schmeck has studied how the respiratory tract reacts to infection with pneumococci, the most important pathogen causing pneumonia.
Researchers have discovered a mechanism that promotes the development of pulmonary fibrosis. An innovative therapeutic approach based on this discovery showed promising results in a preclinical study.
A new building for the Institute for Lung Health (ILH) is being constructed at the DZL site in Gießen, Marburg, Bad Nauheim.
The National Academy of Sciences Leopoldina is Germany's oldest scientific and medical-learned society. DZL researcher Prof. Pullamsetti was admitted to the prestigious Leopoldina.
DZL researchers have found that inhibiting a signaling pathway reduces pathological remodeling of the right ventricle in pulmonary hypertension.
In combination with single-cell technology, human tissue models will accelerate the translation of new antifibrotic agents in the future.
An imaging technique developed by DZL researchers can predict chronic rejection reactions that occur years after transplantation.
DZL scientist Prof. Dr. Silke Meiners investigates lung carcinomas. Her scientific findings show a link between cellular proteasome activity and a lack of response to immunotherapy in the treatment of lung cancer.
DZL scientists have studied the airways of patients with cystic fibrosis and analysed the genetic information of all microorganisms living there.
